Validity, Reliability and Responsiveness of Pain Sensitization Questionnaire

Sponsor
Acibadem University (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT04162730
Collaborator
(none)
150
1
35.6
4.2

Study Details

Study Description

Brief Summary

The aim of this study was to translate the Pain Sensitivity Questionnaire, which was developed to determine the level of pain sensitivity of individuals, to Turkish and to evaluate the validity and reliability of the Turkish version of the scale on knee osteoarthritis patients, and as well as to perform cultural adaptation. Pain sensitivity assessment is used to predict treatment or surgical outcomes of individuals. IPain Sensitivity Questionnaire is a frequently used scale that correlates with experimental pain tests and is used in studies conducted in different patient groups. We believe that adding this scale to our language will contribute to other studies in this field.

Condition or Disease Intervention/Treatment Phase
  • Other: Pressure pain threshold and behavioural data

Study Design

Study Type:
Observational
Anticipated Enrollment :
150 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Validity, Reliability and Responsiveness of Pain Sensitization Questionnaire
Actual Study Start Date :
Jan 8, 2020
Anticipated Primary Completion Date :
Dec 28, 2022
Anticipated Study Completion Date :
Dec 28, 2022

Outcome Measures

Primary Outcome Measures

  1. Pain Sensitivity Questionnaire [1-4 week]

    The Pain Sensitivity Questionnaire was developed to visualize 17 situations that may feel pain in daily life and to indicate possible pain severity. The patient determines the pain severity level from 0 to 10, with 0 indicates no pain, and 10 indicates the most severe pain. The total score of the Pain Sensitivity Questionnaire and the two subscale scores, PSQ-minor and PSQ-moderate, can be calculated. The PSQ-moderate and PSQ-minor subscales consist of 7 items and the total score is calculated on 14 items. The other 3 items were excluded from the scoring of the scale as they normally indicate painless conditions. Total and subscale scores ranged from 0 to 10, and higher scores indicate increased pain sensitivity.

Secondary Outcome Measures

  1. Pain Catastrophization Scale [1-4 week]

    It consists of a total of 13 items and is scored between 0-52 points. Higher scores mean higher levels of pain catastrophization.

  2. Pressure Pain Threshold [One day]

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Not having oral or written communication problems in Turkish,

  • Diagnosis of knee osteoarthritis after clinical examination and radiological imaging,

  • Being 40 years or older,

  • To have neurological competence and cognitive level to answer scale questions.

Exclusion Criteria:
  • To have fibromyalgia syndrome or neurological disease that may affect pain sensitivity levels of individuals,

  • To have undergone surgery involving the knee in the last 1 year,

  • The presence of peripheral neuropathy and neuropathy is therefore to be taking medication.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Özgül Öztürk İ̇stanbul Turkey 34752

Sponsors and Collaborators

  • Acibadem University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Özgül Öztürk, Principal Investigator, Acibadem University
ClinicalTrials.gov Identifier:
NCT04162730
Other Study ID Numbers:
  • ATADEK 2019/17
First Posted:
Nov 14, 2019
Last Update Posted:
Feb 15, 2022
Last Verified:
Feb 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 15, 2022